ArticleCancer medicine2023

Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy-related cognitive impairment in patients with breast cancer who receive chemotherapy.

Senbang Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.